In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • Shoshana Rosenberg, ScD, led a survey that found women who have double mastectomies generally overestimate their likelihood of getting cancer in the healthy breast.

Tags: BreastCancer

  • Dr. Ian E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine significantly prolonged progression-free survival in patients with progressive HER2-positive advanced breast cancer.

Tags: BreastCancer

  • According to Dr. Ann Partridge, new findings suggest that as breast cancer continues to be better characterized molecularly, and therapies such as trastuzumab are developed, the importance of age with regard to prognosis will diminish.

Tags: BasicResearch, BreastCancer

  • Dr. Eric P. Winer co-chaired an expert panel that developed a clinical practice guideline on disease management for patients with advanced HER2-positive breast cancer and brain metastases.

Tags: BreastCancer

  • More than 250 women business and community leaders will gather for the fifth Susan. F. Smith Center for Women's Cancers Executive Council, Beyond Boston Luncheon. The luncheon will include a panel discussion led by Eric P. Winer.

Tags: BreastCancer, CervicalCancer, OvarianCancer, GynecologicCancers

  • Dr. Rachel Freedman commented on a study that finds black women with breast cancer are more likely than Hispanic or white women to experience delays in the initiation of chemotherapy or radiation after surgery.

Tags: BasicResearch, BreastCancer

  • Dr. Eric Winer commented on a blood test that could reduce the number of women who need chemotherapy after tumor removal surgery.

     

Tags: BreastCancer

  • Dr. Huma Rana joins other Boston medical experts to say the latest science backs up Angelina Jolie's choice to undergo a preventive double mastectomy.

Tags: BreastCancer, Genetics, Prevention

  • Dr. Judy Garber and Dr. Eric Winer commented on an experimental medicine that has slowed the pace of advanced breast cancer, doubling the amount of time that patients could live without their tumors advancing.

Tags: BreastCancer

  • Breast cancer surgeons have been having an ongoing discussion on how much tissue to breast tissue to remove when removing a tumor. Dr. Mehra Golshan said that with ductal carcinoma in situ (DCIS), a very treatable, early stage cancer, smaller margins are acceptable and appropriate.

Tags: BreastCancer, Surgery

Showing 1-10 of 69 items